MedPath

Clinical Evaluation of a New Dual-cure Universal Adhesive

Not Applicable
Recruiting
Conditions
Class I Dental Restorations
Class II Dental Restorations
Insufficient Dental Restoration
Caries, Dental
Registration Number
NCT06615544
Lead Sponsor
Ivoclar Vivadent AG
Brief Summary

The overall aim of this study is to evaluate the clinical performance and safety of the new dental dual-cure adhesive for luting indirect ceramic restorations (inlays and onlays). The primary aim is to determine the rate of postoperative hypersensitivity occurrence after using the new adhesive for the placement of indirect restorations. The secondary objective of this study is to assess the long-term clinical performance of the new adhesive in terms of marginal quality, retention/fracture rate of the ceramic restorations, and vitality/fracture rate of the restored teeth.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Age: 18-65 years
  • Informed consent signed and understood by the subject
  • Indication for indirect restorations (inlay, onlay) in molar or premolar
  • The occlusal area of the restoration must cover at least 1/3 of the occlusal area of the tooth.
  • visual analogue scale (VAS)<4 (0=no pain, 10=maximum conceivable pain)
  • Max. 2 restorations per participant in different quadrants.
  • Vital tooth
  • Healthy periodontium, no active periodontitis
  • Contact with adjacent teeth (at least at one side) and opposing teeth present with at least one contact point.
  • Sufficient language skills
Exclusion Criteria
  • Insufficient isolation
  • Participants with a proven allergy to one of the ingredients of the materials used
  • Participants with proven allergy to local anaesthetics
  • High caries activity/ poor oral hygiene
  • Participants with severe systemic diseases
  • Pregnancy
  • Tooth with irreversible pulpitis
  • Indication for direct pulp capping
  • Bleaching of teeth within the last 14 days
  • Usage of peroxide-based disinfectants within the last 14 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Postoperative hypersensitivity1 month

will be assessed according to FDI criteria (grade 1-5, lower scores mean a better outcome)

Secondary Outcome Measures
NameTimeMethod
Fracture rate5 years

will be assessed according to FDI criteria (grade 1-5, lower scores mean a better outcome)

Marginal quality5 years

will be assessed according to FDI criteria (grade 1-5, lower scores mean a better outcome)

Trial Locations

Locations (1)

Ivoclar Vivadent AG

🇱🇮

Schaan, Liechtenstein

Ivoclar Vivadent AG
🇱🇮Schaan, Liechtenstein
Lukas Enggist, Dr. med. dent.
Contact
+423 235 3401
Lukas.Enggist@ivoclar.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.